Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of$ 0.13. This compares to a loss of $0.13 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.69%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of$ 0.18 per share when it actually produced a loss of $0.14, delivering a surprise of +22.22%.Over the last four ...